Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial

OBJECTIVE: Tripterygium wilfordii multiglycosides has been demonstrated to be effective in reducing proteinuria and alleviate edema in patients with chronic kidney disease. We aim to evaluate its efficacy and safety in idiopathic membranous nephropathy. METHODS AND ANALYSIS: This is an randomized, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Chanyu, Li, Qiang, Pu, Lei, Yang, Hongling, Li, Guisen, Feng, Yunlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830847/
https://www.ncbi.nlm.nih.gov/pubmed/35147131
http://dx.doi.org/10.1097/MD.0000000000028842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830847/
https://www.ncbi.nlm.nih.gov/pubmed/35147131
http://dx.doi.org/10.1097/MD.0000000000028842

Ejemplares similares